10-Q
XBRL
QUARTERLY REPORT
- Company
- ABVC BIOPHARMA, INC.
- Filed
- November 3, 2025
- Period of Report
- September 30, 2025
- Accession Number
- 0001213900-25-104811
A 10-Q is a quarterly financial report filed after each of the first three quarters of a fiscal year. It includes unaudited financial statements and management commentary. Learn more about 10-Q filings →